Literature DB >> 3989888

The role of physiologic monitoring in patients with fractures of the hip.

R J Schultz, G F Whitfield, J J LaMura, A Raciti, S Krishnamurthy.   

Abstract

Mortality rates for elderly patients with hip fractures have been reported to be as high as 37%. This study evaluated 70 patients of whom 35 were evaluated preoperatively by conventional diagnostic means, and 35 in whom hemodynamic, respiratory, and metabolic status was assessed using a Swan-Ganz balloon-tipped catheter. The derived variables were then calculated by a minicomputer and automatically plotted on a printed graphic display in a bar graph format. This diagnostic modality permitted appreciation of occult physiologic aberrations not detected by conventional methods, enabling correction of these abnormalities preoperatively and postoperatively. The study demonstrated a mortality rate of 2.9% in the monitored group compared to a 29% mortality in the nonmonitored group. The intrinsic assumption that patients should undergo surgery within 24 hours (3) was also modified. The appropriate time for surgery should be accurately determined and chosen on the basis of optimal physiologic balance.

Entities:  

Mesh:

Year:  1985        PMID: 3989888     DOI: 10.1097/00005373-198504000-00005

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  20 in total

1.  Quality effects of operative delay on mortality in hip fracture treatment.

Authors:  R Sund; A Liski
Journal:  Qual Saf Health Care       Date:  2005-10

Review 2.  What type of monitoring has been shown to improve outcomes in acutely ill patients?

Authors:  Gustavo A Ospina-Tascón; Ricardo L Cordioli; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2008-01-05       Impact factor: 17.440

3.  Our study 20 years on: a randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients.

Authors:  Owen Boyd; R Michael Grounds
Journal:  Intensive Care Med       Date:  2013-10-01       Impact factor: 17.440

4.  Cerebral oximetry during preoperative resuscitation in elderly patients with hip fracture: a prospective observational study.

Authors:  C G Clemmesen; L M Pedersen; S Hougaard; M L Andersson; V Rosenkvist; H B Nielsen; H Palm; N B Foss
Journal:  J Clin Monit Comput       Date:  2018-02-05       Impact factor: 2.502

5.  Intravascular volume optimisation during repair of proximal femoral fracture. Intravascular volume was depleted perioperatively in control group.

Authors:  K W Toh; W J Fawcett
Journal:  BMJ       Date:  1998-04-04

Review 6.  Automated systems for perioperative goal-directed hemodynamic therapy.

Authors:  Sean Coeckelenbergh; Cedrick Zaouter; Brenton Alexander; Maxime Cannesson; Joseph Rinehart; Jacques Duranteau; Philippe Van der Linden; Alexandre Joosten
Journal:  J Anesth       Date:  2019-09-25       Impact factor: 2.078

Review 7.  [Perioperative fluid management: an analysis of the present situation].

Authors:  Y A Zausig; M A Weigand; B M Graf
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

8.  Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective, randomized clinical trial.

Authors:  J F Berlauk; J H Abrams; I J Gilmour; S R O'Connor; D R Knighton; F B Cerra
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

Review 9.  Perioperative fluid volume optimization following proximal femoral fracture.

Authors:  Sharon R Lewis; Andrew R Butler; Andrew Brammar; Amanda Nicholson; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-03-14

10.  Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006.

Authors:  Massimo Antonelli; Mitchell Levy; Peter J D Andrews; Jean Chastre; Leonard D Hudson; Constantine Manthous; G Umberto Meduri; Rui P Moreno; Christian Putensen; Thomas Stewart; Antoni Torres
Journal:  Intensive Care Med       Date:  2007-04       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.